Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» hepatitis D
hepatitis D
Assembly Bio to launch four infectious disease trials in 2024
Clinical Trials Arena
Mon, 03/18/24 - 11:14 am
Assembly Bio
clinical trials
herpes simplex virus
hepatitis B
hepatitis D
Bluejay Therapeutics makes progress in Hepatitis B and D Trials
Clinical Trials Arena
Fri, 06/2/23 - 10:20 am
Bluejay Therapeutics
clinical trials
BJT-778
hepatitis B
hepatitis D
After FDA rejection, Gilead nears full EU nod for hep D drug
Pharmaphorum
Fri, 05/5/23 - 11:15 am
Gilead Sciences
hepatitis D
FDA
Europe
Hepcludex
buleviritide
Gilead's Hopes for HDV Approval Delayed after CRL
BioSpace
Sun, 10/30/22 - 04:15 pm
Gilead Sciences
hepatitis D
FDA
buleviritide
Vir doses first subject in Phase II hepatitis D virus treatment trial
Clinical Trials Arena
Fri, 09/23/22 - 10:32 am
Vir Biotechnology
hepatitis D
VIR-2218
VIR-3434
clinical trials
Gilead preps filing for hepatitis D therapy Hepcludex in US
Pharmaforum
Fri, 06/25/21 - 11:03 am
Gilead Sciences
Hepcludex
hepatitis D
Gilead inks a billion-dollar deal for a hepatitis drug
BioPharma Dive
Thu, 12/10/20 - 10:47 am
Gilead Sciences
Myr Pharmaceuticals
hepatitis D
M&A